Report : South and Central America Blood Filter Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (40 Microns and 70 Microns, 100 Microns and 170 Microns, and Others), Material (Polycarbonate, Polyester, ABS, and Others), Application (Blood Processing and Blood Transfusion), and End User (Blood Banks, Hospitals, and Others)
Blood Transfusion Segment to Dominate South and Central America Blood Filter Market during 2019–2028
According to a new market research study on “South and Central America Blood Filter Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Material, Application, and End User,” is expected to reach US$ 22,710.90 thousand by 2028 from US$ 17,667.87 thousand in 2021. The market is estimated to grow at a CAGR of 3.7% from 2021 to 2028. Rapid increase in burden of chronic diseases is the major factor driving the growth of the South and Central America blood filter market. However, product recalls may hinder the growth of South and Central America blood filter market. The report provides trends prevailing in the South and Central America blood filter market along with the drivers and restraints pertaining to the market growth.
In South and Central America, Brazil, Peru, Chile, Ecuador, and Venezuela have reported a large number of COVID-19 cases. Many countries in South America have underdeveloped healthcare infrastructure. For instance, Peru has less than 1000 intensive care unit beds for its 32 million inhabitants. Supply chain disruptions caused due to the congestion of ports and disturbances in other transport means had a substantial impact on the distribution of associated devices in the region. All these factors considerably deterred the growth of the South and Central America blood filter market. Further, with the redirected focus on managing COVID-19 cases, the non-urgent medical procedures were delayed in hospitals in South and Central American countries. Several clinics have postponed or dropped numerous elective surgeries, especially those that are considered non-urgent. This led to reduced demand for blood filters due to the lowered blood transfusion procedures.
The South and Central America blood filter market is segmented into product, application, material, end user, and country. The South and Central America blood filter market, by product, is segmented into 40 Microns and 70 Microns, 100 Microns and 170 Microns, and others. The 100 microns to 170 microns segment held the largest share of the market in 2021. The South and Central America blood filter market, by material, is segmented into polycarbonate, polyester, ABS, and others. The polyester segment held the largest share of the market in 2021. The South and Central America blood filter market, by application, is segmented into blood processing and blood transfusion. The blood transfusion segment held the largest share of the market in 2021. On the basis of blood transfusion, the market is further segmented into whole blood, red cell, and plasma and platelet filtration. The plasma and platelet filtration segment accounts for largest market share in the 2021. Based on end user, the South and Central America blood filter market is segmented blood banks, hospitals, and others. The blood banks segment held the largest share of the market in 2021. Similarly, based on country, the market is bifurcated into Brazil, Argentina, and rest of South and Central America. Brazil contributed a substantial share in 2021.
Asahi Kasei Corporation; Fresenius Kabi AG; Haemonetics Corporation; KANEKA CORPORATION; Kawasumi laboratories. Inc.; Macopharma; Nanjing Shuangwei Biotechnology Co., Ltd.; Sefar AG; and Shandong Zhongbaokang Medical Implements Co., Ltd are among the leading companies in the South and Central America Blood Filter Market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, ExThera Medical’s Seraph 100 Microbind Affinity Filter (Seraph 100) is distributed in South and Central America by Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases. The two companies signed a co-marketing and distribution agreement earlier this year.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org